Page last updated: 2024-08-17

cycloserine and Anxiety Neuroses

cycloserine has been researched along with Anxiety Neuroses in 45 studies

Research

Studies (45)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (2.22)	18.7374
1990's	0 (0.00)	18.2507
2000's	12 (26.67)	29.6817
2010's	30 (66.67)	24.3611
2020's	2 (4.44)	2.80

Authors

Authors	Studies
Carpenter, JK; Dowd, SM; Dutcher, CD; Fitzgerald, HE; Hofmann, SG; Lubin, RE; Otto, MW; Papini, S; Pollack, MH; Rosenfield, D; Smits, JAJ	1
Altemus, M; Anderson, P; Andersson, E; Cukor, J; Davis, M; de Kleine, RA; de la Cruz, LF; Difede, J; Dunlop, BW; Farrell, LJ; Finck, C; Frumento, P; Geffken, GR; Geller, D; Gerardi, M; Golfels, F; Goodman, WK; Guastella, AJ; Gutner, CA; Hendriks, GJ; Heyman, I; Hofmann, SG; Jovanovic, T; Kushner, MG; Lee, FS; Lenze, EJ; Levinson, CA; Lewin, AB; Mataix-Cols, D; McConnell, H; McNamara, JP; Monzani, B; Murphy, TK; Norrholm, S; Otto, MW; Pérez-Vigil, A; Plag, J; Pollack, MH; Ressler, KJ; Rodebaugh, TL; Rosenfield, D; Rothbaum, BO; Rück, C; Smits, JAJ; Storch, EA; Ströhle, A; Tart, CD; Thuras, P; Tolin, DF; Turner, C; van Minnen, A; Waters, AM; Weems, CF; Wilhelm, S; Wyka, K	1
Alavi, N; Baird, SO; Dutcher, CD; Kauffman, BY; Lee-Furman, E; Otto, MW; Papini, S; Piper, ME; Rosenfield, B; Rosenfield, D; Smits, JAJ; Zvolensky, MJ	1
Daniels, WMU; Fairbairn, L; Gamieldien, J; Hart, S; Hemmings, SMJ; Jalali Sefid Dashti, M; Kidd, M; Malan-Müller, S; Seedat, S	1
Bhushan, A; Desai, V; Kaushal, G; Kokate, R; Shin, Y	1
Lenze, EJ; Rodebaugh, TL	1
Davis, ML; Hofmann, SG; Marques, L; Meuret, AE; Otto, MW; Pollack, MH; Rosenfield, D; Simon, NM; Smits, JA	1
Dodds, A; Rapp, A; Rynn, M; Walkup, JT	1
Hofmann, SG	2
Lewin, AB; McGuire, JF; Storch, EA	1
Coutinho, ES; Figueira, I; Gonçalves, R; Lopes, A; Mendlowicz, MV; Rodrigues, H; Ventura, P	1
Hofmann, SG; Otto, MW; Pollack, MH; Smits, JA	1
Lonak, SF; Marin, MF; Milad, MR	1
Amos, T; Bergman, H; Ipser, JC; Ori, R; Soares-Weiser, K; Stein, DJ	1
Carpenter, JK; Hofmann, SG; Otto, MW; Pollack, MH; Rosenfield, D; Smits, JA	1
Becker, ES; de Kleine, RA; Hendriks, GJ; Smits, JA; van Minnen, A	1
de Kleine, RA; Evins, AE; Hofmann, SG; Kredlow, MA; Otto, MW; Pollack, MH; Smits, JAJ; Tolin, DF; van Minnen, A	1
McCracken, JT; McGuire, JF; Piacentini, J; Storch, EA; Wu, MS	1
Favaron, E; Günthner, J; Harmer, CJ; Johansen-Berg, H; Reinecke, A; Scholl, J	1
Hudson, JL; Jones, MP; Lyneham, HJ; Malhi, GS; Rapee, RM; Schneider, SC	1
Altemus, M; Anderson, P; Andersson, E; Cukor, J; Davis, M; de Kleine, RA; Difede, J; Dunlop, BW; Farrell, LJ; Fernández de la Cruz, L; Finck, C; Frumento, P; Geffken, GR; Geller, D; Gerardi, M; Golfels, F; Goodman, WK; Guastella, AJ; Gutner, C; Hendriks, GJ; Heyman, I; Hofmann, SG; Jovanovic, T; Kushner, MG; Lee, FS; Lenze, EJ; Levinson, CA; Lewin, AB; Mataix-Cols, D; McConnell, H; McNamara, JP; Monzani, B; Murphy, TK; Norrholm, S; Otto, MW; Pérez-Vigil, A; Plag, J; Pollack, MH; Ressler, KJ; Rodebaugh, TL; Rosenfield, D; Rothbaum, BO; Rück, C; Scheeringa, MS; Siewert-Siegmund, A; Smits, JAJ; Storch, EA; Ströhle, A; Tart, CD; Thuras, P; Tolin, DF; van Minnen, A; Waters, AM; Weems, CF; Wilhelm, S; Wyka, K	1
Michopoulos, V	1
Bittner, N; Buhlmann, U; Bürkner, PC; Holling, H	1
Amaral, OB; Roesler, R	1
McKay, D; Tryon, WW	1
Ganasen, KA; Ipser, JC; Stein, DJ	1
Bidziński, A; Hamed, A; Lehner, M; Maciejak, P; Płaźnik, A; Skórzewska, A; Sobolewska, A; Szyndler, J; Taracha, E; Turzyńska, D; Wisłowska-Stanek, A	1
Sanders, KB; Veenstra-VanderWeele, J; Warren, ZE	1
Asnaani, A; Gutner, CA; Hofmann, SG; Otto, MW; Smits, JA	1
Choi, DC; Gerardi, M; Ressler, KJ; Rothbaum, BO	1
Davis, M	1
Bloch, MH; Bontempo, A; Panza, KE	1
Asnaani, A; Hofmann, SG; Sawyer, AT	1
Honma, M; Kim, Y; Kuriyama, K; Yoshiike, T	1
Birk, L	1
Gillespie, CF; Ressler, KJ	1
Bertotto, ME; Bustos, SG; Martijena, ID; Molina, VA	1
Basden, SL; Hofmann, SG; Leyro, TM; McHugh, RK; Otto, MW	1
McNally, RJ	1
Broft, A; Schebendach, J; Steinglass, J; Strober, M; Sysko, R; Walsh, BT	1
Krystal, JH; Norberg, MM; Tolin, DF	1
Langton, JM; Richardson, R	1
Koch, M	1
Popkowska, N	1

Reviews

27 review(s) available for cycloserine and Anxiety Neuroses

Article	Year
Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis. Journal of anxiety disorders, 2019, Volume: 68 Topics: Adolescent; Adult; Aged; Anxiety; Anxiety Disorders; Child; Combined Modality Therapy; Cycloserine; Female; Humans; Implosive Therapy; Male; Middle Aged; Treatment Outcome; Young Adult	2019
Lessons learned from D-cycloserine: the promise and limits of drug facilitation of exposure therapy. The Journal of clinical psychiatry, 2013, Volume: 74, Issue:4 Topics: Animals; Antimetabolites; Anxiety Disorders; Combined Modality Therapy; Cycloserine; Humans; Implosive Therapy; N-Methylaspartate; Treatment Outcome	2013
Treatment of pediatric anxiety disorders. Annals of the New York Academy of Sciences, 2013, Volume: 1304 Topics: Adolescent; Anticonvulsants; Anxiety Disorders; Anxiety, Separation; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Humans; Obsessive-Compulsive Disorder; Phobic Disorders; Riluzole; Stress Disorders, Post-Traumatic	2013
D-cycloserine for treating anxiety disorders: making good exposures better and bad exposures worse. Depression and anxiety, 2014, Volume: 31, Issue:3 Topics: Antibiotics, Antitubercular; Anxiety Disorders; Combined Modality Therapy; Cycloserine; Humans; Implosive Therapy; Receptors, N-Methyl-D-Aspartate	2014
Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder. Expert review of neurotherapeutics, 2014, Volume: 14, Issue:8 Topics: Animals; Anxiety Disorders; Behavior Therapy; Cycloserine; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Stress Disorders, Post-Traumatic; Yohimbine	2014
Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis. PloS one, 2014, Volume: 9, Issue:7 Topics: Antimetabolites; Anxiety Disorders; Cycloserine; Double-Blind Method; Female; Humans; Male; PubMed; Randomized Controlled Trials as Topic	2014
D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update. Current psychiatry reports, 2015, Volume: 17, Issue:1 Topics: Antimetabolites; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Humans	2015
Augmentation of Evidence-Based Psychotherapy for PTSD With Cognitive Enhancers. Current psychiatry reports, 2015, Volume: 17, Issue:6 Topics: Adrenergic beta-Antagonists; Animals; Anxiety Disorders; Cycloserine; Endocannabinoids; Estrogens; Evidence-Based Medicine; Histone Deacetylase Inhibitors; Humans; Methylene Blue; Nootropic Agents; Psychotherapy; Stress Disorders, Post-Traumatic	2015
Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders. The Cochrane database of systematic reviews, 2015, May-10, Issue:5 Topics: Adolescent; Adult; Aged; Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Humans; Middle Aged; Randomized Controlled Trials as Topic	2015
Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions. Biological psychiatry, 2016, 08-15, Volume: 80, Issue:4 Topics: Antimetabolites; Anxiety Disorders; Combined Modality Therapy; Cycloserine; Extinction, Psychological; Humans; Implosive Therapy	2016
A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission. The Journal of clinical psychiatry, 2017, Volume: 78, Issue:2 Topics: Adolescent; Adult; Aged; Anxiety Disorders; Child; Combined Modality Therapy; Cycloserine; Female; Humans; Implosive Therapy; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychometrics; Randomized Controlled Trials as Topic; Stress Disorders, Post-Traumatic; Treatment Outcome; Young Adult	2017
D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data. JAMA psychiatry, 2017, 05-01, Volume: 74, Issue:5 Topics: Antidepressive Agents; Anxiety Disorders; Combined Modality Therapy; Cycloserine; Drug Synergism; Excitatory Amino Acid Agonists; Humans; Implosive Therapy; N-Methylaspartate; Obsessive-Compulsive Disorder; Outcome Assessment, Health Care; Stress Disorders, Post-Traumatic	2017
D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis. PloS one, 2017, Volume: 12, Issue:3 Topics: Anxiety Disorders; Bayes Theorem; Cycloserine; Humans; Implosive Therapy; Obsessive-Compulsive Disorder	2017
Targeting the NMDA receptor for fear-related disorders. Recent patents on CNS drug discovery, 2008, Volume: 3, Issue:3 Topics: Anxiety Disorders; Cycloserine; Fear; Humans; Memory; Receptors, N-Methyl-D-Aspartate	2008
Memory modification as an outcome variable in anxiety disorder treatment. Journal of anxiety disorders, 2009, Volume: 23, Issue:4 Topics: Anti-Anxiety Agents; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Humans; Learning; Memory Disorders; Obsessive-Compulsive Disorder; Stress Disorders, Post-Traumatic; Treatment Outcome	2009
Augmentation of cognitive behavioral therapy with pharmacotherapy. The Psychiatric clinics of North America, 2010, Volume: 33, Issue:3 Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Drug Therapy; Extinction, Psychological; Humans; Randomized Controlled Trials as Topic; Substance-Related Disorders	2010
Cognitive enhancers for anxiety disorders. Pharmacology, biochemistry, and behavior, 2011, Volume: 99, Issue:2 Topics: Animals; Anxiety Disorders; Benzhydryl Compounds; Caffeine; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Extinction, Psychological; Humans; Learning; Modafinil; Neurotransmitter Agents; Nootropic Agents; Translational Research, Biomedical; Yohimbine	2011
Pharmacological enhancement of behavioral therapy: focus on posttraumatic stress disorder. Current topics in behavioral neurosciences, 2010, Volume: 2 Topics: Animals; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Desensitization, Psychologic; Extinction, Psychological; Eye Movement Desensitization Reprocessing; Humans; Hypnosis; Implosive Therapy; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders; Receptors, N-Methyl-D-Aspartate; Stress Disorders, Post-Traumatic; Treatment Outcome	2010
NMDA receptors and fear extinction: implications for cognitive behavioral therapy. Dialogues in clinical neuroscience, 2011, Volume: 13, Issue:4 Topics: Amygdala; Animals; Anxiety Disorders; Cognitive Behavioral Therapy; Cycloserine; Extinction, Psychological; Fear; Humans; Receptors, N-Methyl-D-Aspartate	2011
D-cycloserine augmentation of behavioral therapy for the treatment of anxiety disorders: a meta-analysis. The Journal of clinical psychiatry, 2012, Volume: 73, Issue:4 Topics: Anti-Anxiety Agents; Anxiety Disorders; Behavior Therapy; Combined Modality Therapy; Cycloserine; Humans; Treatment Outcome	2012
D-cycloserine as an augmentation strategy for cognitive behavioral therapy for anxiety disorders: an update. Current pharmaceutical design, 2012, Volume: 18, Issue:35 Topics: Animals; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Dose-Response Relationship, Drug; Humans; Memory; Randomized Controlled Trials as Topic; Receptors, N-Methyl-D-Aspartate; Time Factors; Treatment Outcome	2012
Pharmacotherapy for performance anxiety disorders: occasionally useful but typically contraindicated. Journal of clinical psychology, 2004, Volume: 60, Issue:8 Topics: Antimetabolites; Anxiety Disorders; Cycloserine; Extinction, Psychological; Fear; Humans; Panic Disorder; Speech; Task Performance and Analysis	2004
Emotional learning and glutamate: translational perspectives. CNS spectrums, 2005, Volume: 10, Issue:10 Topics: Animals; Anxiety Disorders; Behavior Therapy; Brain; Cycloserine; Disease Models, Animal; Emotions; Extinction, Psychological; Fear; Glutamic Acid; Humans; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Rodentia	2005
Clinical perspectives on the combination of D-cycloserine and cognitive-behavioral therapy for the treatment of anxiety disorders. CNS spectrums, 2007, Volume: 12, Issue:1 Topics: Animals; Anxiety Disorders; Brain; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Desensitization, Psychologic; Disease Models, Animal; Fear; Humans; Randomized Controlled Trials as Topic	2007
Mechanisms of exposure therapy: how neuroscience can improve psychological treatments for anxiety disorders. Clinical psychology review, 2007, Volume: 27, Issue:6 Topics: Amygdala; Animals; Anti-Anxiety Agents; Anxiety Disorders; Arousal; Brain; Cognitive Behavioral Therapy; Cycloserine; Desensitization, Psychologic; Dominance, Cerebral; Extinction, Psychological; Fear; Humans; Mental Recall; Nerve Net; Prefrontal Cortex; Rats; Receptors, N-Methyl-D-Aspartate	2007
Enhancing exposure-based therapy from a translational research perspective. Behaviour research and therapy, 2007, Volume: 45, Issue:9 Topics: Anti-Anxiety Agents; Anxiety Disorders; Combined Modality Therapy; Cycloserine; Desensitization, Psychologic; Extinction, Psychological; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders	2007
A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biological psychiatry, 2008, Jun-15, Volume: 63, Issue:12 Topics: Animals; Anxiety Disorders; Combined Modality Therapy; Cycloserine; Desensitization, Psychologic; Extinction, Psychological; Fear; Humans; Implosive Therapy; Neuronal Plasticity; Receptors, N-Methyl-D-Aspartate; Treatment Outcome	2008

Trials

8 trial(s) available for cycloserine and Anxiety Neuroses

Article	Year
Enhancing panic and smoking reduction treatment with D-Cycloserine: A pilot randomized clinical trial. Drug and alcohol dependence, 2020, 03-01, Volume: 208 Topics: Adolescent; Adult; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder; Pilot Projects; Smokers; Smoking; Smoking Cessation; Smoking Reduction; Treatment Outcome; Young Adult	2020
D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions. Journal of psychiatric research, 2013, Volume: 47, Issue:10 Topics: Adult; Antidepressive Agents; Anxiety Disorders; Cycloserine; Double-Blind Method; Fear; Female; Humans; Implosive Therapy; Male; Models, Statistical; Severity of Illness Index; Young Adult	2013
Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale. Contemporary clinical trials, 2015, Volume: 43 Topics: Anxiety Disorders; Combined Modality Therapy; Cycloserine; Double-Blind Method; Heart Rate; Humans; Hydrocortisone; Implosive Therapy; Psychiatric Status Rating Scales; Research Design; Saliva; Severity of Illness Index; Sleep	2015
Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder. Journal of anxiety disorders, 2015, Volume: 34 Topics: Anti-Anxiety Agents; Anxiety Disorders; Combined Modality Therapy; Cycloserine; Double-Blind Method; Extinction, Psychological; Fear; Female; Humans; Implosive Therapy; Learning; Male; Self Report; Stress Disorders, Post-Traumatic; Treatment Outcome	2015
The NMDA receptor partial agonist d-cycloserine does not enhance motor learning. Journal of psychopharmacology (Oxford, England), 2016, Volume: 30, Issue:10 Topics: Adult; Anxiety Disorders; Cognition; Cognitive Behavioral Therapy; Cycloserine; Double-Blind Method; Female; Humans; Learning; Male; Motor Activity; Receptors, N-Methyl-D-Aspartate; Young Adult	2016
d-Cycloserine does not enhance the effects of in vivo exposure among young people with broad-based anxiety disorders. Behaviour research and therapy, 2016, Volume: 87 Topics: Adolescent; Anxiety Disorders; Child; Combined Modality Therapy; Cycloserine; Double-Blind Method; Female; Humans; Implosive Therapy; Male; Nootropic Agents	2016
Valproic acid but not D-cycloserine facilitates sleep-dependent offline learning of extinction and habituation of conditioned fear in humans. Neuropharmacology, 2013, Volume: 64 Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Cycloserine; Excitatory Amino Acid Agonists; Extinction, Psychological; Fear; Female; Habituation, Psychophysiologic; Histone Deacetylase Inhibitors; Humans; Learning; Male; Memory, Episodic; Molecular Targeted Therapy; Nootropic Agents; Receptors, N-Methyl-D-Aspartate; Single-Blind Method; Sleep; Students; Valproic Acid; Young Adult	2013
The application of exposure therapy and D-cycloserine to the treatment of anorexia nervosa: a preliminary trial. Journal of psychiatric practice, 2007, Volume: 13, Issue:4 Topics: Adult; Anorexia Nervosa; Anxiety Disorders; Body Mass Index; Combined Modality Therapy; Cycloserine; Desensitization, Psychologic; Double-Blind Method; Eating; Energy Intake; Excitatory Amino Acid Agonists; Female; Follow-Up Studies; Humans; Pain Measurement; Patient Admission; Receptors, N-Methyl-D-Aspartate	2007

Other Studies

10 other study(ies) available for cycloserine and Anxiety Neuroses

Article	Year
Using pre-treatment de novo threat conditioning outcomes to predict treatment response to DCS augmentation of exposure-based CBT. Journal of psychiatric research, 2023, Volume: 164 Topics: Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Extinction, Psychological; Humans; Treatment Outcome	2023
The role of microRNAs in the therapeutic action of D-cycloserine in a post-traumatic stress disorder animal model: an exploratory study. Psychiatric genetics, 2017, Volume: 27, Issue:4 Topics: Animals; Anxiety; Anxiety Disorders; Conditioning, Classical; Cycloserine; Disease Models, Animal; Extinction, Psychological; Fear; High-Throughput Nucleotide Sequencing; Hippocampus; Male; Memory; MicroRNAs; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Stress Disorders, Post-Traumatic	2017
D-cycloserine nasal formulation development for anxiety disorders by using polymeric gels. Drug discoveries & therapeutics, 2018, Volume: 12, Issue:3 Topics: Administration, Intranasal; Antimetabolites; Anxiety Disorders; Cell Line, Tumor; Cellulose; Chromatography, High Pressure Liquid; Cycloserine; Drug Delivery Systems; Drug Partial Agonism; Electric Impedance; Excipients; Gels; Humans; Hydrogen-Ion Concentration; Hypromellose Derivatives; Implosive Therapy; In Vitro Techniques; Methylcellulose; Nasal Cavity; Nasal Mucosa; Poloxamer; Polymers; Receptors, N-Methyl-D-Aspartate; Viscosity	2018
Enhancing cognitive behavioral therapy: Is the finish line in sight? Science translational medicine, 2017, 03-01, Volume: 9, Issue:379 Topics: Anxiety; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cycloserine; Humans; Obsessive-Compulsive Disorder; Stress Disorders, Post-Traumatic	2017
The effects of midazolam and D-cycloserine on the release of glutamate and GABA in the basolateral amygdala of low and high anxiety rats during extinction trial of a conditioned fear test. Neurobiology of learning and memory, 2010, Volume: 94, Issue:4 Topics: Amygdala; Analysis of Variance; Animals; Anxiety; Anxiety Disorders; Conditioning, Classical; Cycloserine; Disease Models, Animal; Drug Interactions; Extinction, Psychological; Fear; Freezing Reaction, Cataleptic; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Male; Midazolam; Neurotransmitter Agents; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Statistics, Nonparametric	2010
Identity crisis involving body image in a young man with autism. The American journal of psychiatry, 2010, Volume: 167, Issue:11 Topics: Adolescent; Anticonvulsants; Anxiety Disorders; Autistic Disorder; Behavior Therapy; Body Dysmorphic Disorders; Body Image; Child; Combined Modality Therapy; Cycloserine; Depressive Disorder, Major; Follow-Up Studies; Humans; Identity Crisis; Lamotrigine; Patient Care Team; Psychotherapy; Psychotropic Drugs; Socialization; Triazines; Young Adult	2010
Influence of ethanol withdrawal on fear memory: Effect of D-cycloserine. Neuroscience, 2006, Nov-03, Volume: 142, Issue:4 Topics: Alcohol-Induced Disorders, Nervous System; Animals; Antimetabolites; Anxiety Disorders; Brain; Brain Chemistry; Central Nervous System Depressants; Conditioning, Psychological; Cycloserine; Disease Models, Animal; Drug Synergism; Ethanol; Extinction, Psychological; Fear; Male; Memory; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome; Synaptic Transmission	2006
D-cycloserine facilitates extinction the first time but not the second time: an examination of the role of NMDA across the course of repeated extinction sessions. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:13 Topics: Acoustic Stimulation; Animals; Anxiety Disorders; Avoidance Learning; Brain; Conditioning, Psychological; Cycloserine; Disease Models, Animal; Excitatory Amino Acid Agonists; Extinction, Psychological; Fear; Male; Memory; Neuropsychological Tests; Photic Stimulation; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reflex, Startle	2008
[Pharmacological support of exposure therapy in anxiety disorders. Animal experiment studies]. Der Nervenarzt, 2002, Volume: 73, Issue:5 Topics: Animals; Anxiety Disorders; Combined Modality Therapy; Conditioning, Classical; Cycloserine; Desensitization, Psychologic; Extinction, Psychological; Fear; Humans; Receptors, N-Methyl-D-Aspartate; Reflex, Startle	2002
[Anxiety-paranoic psychosis in the course of treatment with cycloserine]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 1966, Apr-15, Volume: 19, Issue:8 Topics: Adult; Anxiety Disorders; Cycloserine; Female; Humans; Paranoid Disorders	1966